This report is being filed on an international product, glp aliquot module, list number 06q12-01, which has a same/similar component of the modular glp systems track registered in the us, list number 04z96-51.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
The field service representative (fsr) reported that the wrong patient¿s name was printed on to the secondary sample tube label for the glp aliquot module (am), serial (b)(6).As the patient¿s name was long, no tests were performed for the secondary tube and no impact to patient management was reported.During an investigation into this issue, it was found that the glp am was not upgraded to software version 2.1.1 for aliquot module at the time of the incident.Further investigation identified that free text fields for secondary tube labels are limited to 49 characters.When 50 characters or more are used, the aliquot module (am) may print labels with text information from other labels.Although the text information is incorrect, the barcode readable information remains correct.Based on the available information, a deficiency was identified for the glp aliquot module (am) (list number 06q12-01).A product correction letter was issued on 15aug2023 to all customers with installed glp track and aliquot module (am) (list number 06q12-01), notifying them of the potential performance issue.Additionally, the product correction letter informs the customer of the following necessary action that is required until software version is updated.Abbott service representative will contact the customer to schedule a mandatory upgrade when the software is available for each module.This report is being filed on an international product, glp module (list number 06q12-01), which has a same/similar component of the modular glp track system registered in the us, list number 04z965-20.Note: the impacted product is not distributed in the us.
|